SCHEMBL31542330

SCHEMBL31542330

Cc1cc2c(N3CCN(C)c4ccc(C#N)cc43)cc(N3CCC4(CC3)CCN(c3ccc(N)cc3F)CC4)cc2n(C)c1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ADRA1D P25100 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ ADRA1B P35368 1/20 0.33
▸ PARP1 P09874 4/20 0.33
▸ PARP2 Q9UGN5 2/20 0.33
▸ ACACA Q13085 1/20 0.31
▸ GPR6 P46095 1/20 0.31
▸ BRPF1 P55201 1/20 0.31
▸ TNK1 Q13470 2/20 0.30
▸ ALK Q9UM73 2/20 0.30
▸ TNK2 Q07912 1/20 0.30
▸ USP14 P54578 1/20 0.30
▸ KCNJ1 P48048 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542335 0.90 SLC6A5 (0.39) FFAR4ALDH1A1LMNAMAPTADRA1D
SCHEMBL31542280 0.84 GPR6 (0.35) ALDH1A1ADRA1DADRA1AADRA1BPARP1
SCHEMBL31542233 0.83 CRBN (0.36) FFAR4ADRA1DADRA1AADRA1BPARP1
SCHEMBL31542294 0.82 DRD2 (0.37) BRPF1ALK
SCHEMBL31542319 0.79 ALK (0.35) FFAR4ALDH1A1GPR6BRPF1ALK
SCHEMBL31542179 0.78 CRBN (0.32) FFAR4ADRA1DADRA1AADRA1BALK
SCHEMBL31542341 0.78 CHRM4 (0.36) ADRA1DADRA1AADRA1BPARP1PARP2
SCHEMBL31542332 0.77 EGLN2 (0.44) ALDH1A1LMNAMAPT
SCHEMBL31542270 0.76 BRPF1 (0.34) ALDH1A1GPR6BRPF1ALKKDM1A
SCHEMBL31542279 0.75 BRPF1 (0.35) FFAR4ALDH1A1GPR6BRPF1USP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025062330-A1 HETEROCYCLIC COMPOUNDS AS CBP SELECTIVE DEGRADERS AURIGENE ONCOLOGY LIMITED (IN) 2025-03-27 — — WO disclosed
Send feedback